Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 155   

Articles published

AZN 4,021.79 +10.29 (0.26%)
price chart
AstraZeneca plc (4.71%), Centrica plc (5.87%) and United Utilities Group plc ...
Pharmaceutical play AstraZeneca (LSE: AZN) has a strong dividend track record, and right now offers an annual 4.71% cash injection for your portfolio.
3 growth greats for your shares portfolio! AstraZeneca plc, Diageo plc and ...
I have long argued that spirits manufacturer Diageo (LSE: DGE) is a terrific growth option thanks to its robust position in established and emerging regions alike.
Why AstraZeneca plc and Shire plc are 2 growth stars
30 years ago cancer was a disease that was almost incurable. Today, more people survive cancer than die from it. The world - particularly science and technology - continues to make real progress, day after day, and year after year.
AstraZeneca plc may never recover, is it time to buy Hikma Pharmaceuticals plc?
However, not all pharma groups are created equal, and the fortunes of two of the industry's biggest players, AstraZeneca(LSE: AZN) and Hikma Pharmaceuticals(LSE: HIK) couldn't be more different.
Could AstraZeneca plc (ADR) See a Reversal After Today's Strong Options Activity?
In today's session AstraZeneca plc (ADR) (AZN) registered an unusually high (308) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the June, 2016 call, expecting serious AZN increase.
Notable Analysts Recommendation to Monitor: Astrazeneca PLC (NYSE:AZN ...  Street Updates
Astrazeneca PLC (NYSE:AZN) Analyst Review  Risers & Fallers
AstraZeneca plc (NYSE:AZN) Received Positive Phase 3 Data Amidst Stiffening ...
AstraZeneca plc (NYSE:AZN) announced that it has received positive phase 3 results on benralizumab, its candidate for severe asthma.
Where AstraZeneca plc (ADR) (NYSE:AZN) Stands on Analytical Review Chart?  The Point Review
Holowesko Partners LTD Increased Astrazeneca Plc (NYSE:AZN) by $12.82 ...  CCH Daily News
Are AstraZeneca plc, Eco Animal Health Group plc and Advanced Medical ...
One company that has stuttered somewhat on the growth front in recent years is AstraZeneca (LSE: AZN). In fact, its bottom line has fallen heavily as a loss of patents on key drugs has hurt sales, but with an acquisition programme set to deliver growth ...
Overhang For Relypsa Remains, Morgan Stanley Says
A probable delay in the FDA approval of ZS-9, AstraZeneca plc's (ADR) AZN 0.23% hyperkalaemia asset, could lend near-term upside to shares of Relypsa Inc RLYP 8.8%.
Relypsa Inc Surges on FDA Rejection of AstraZeneca's ZS-9  Bidness ETC
AstraZeneca plc, Relypsa Inc Diverge on FDA Drug Rejection  Schaeffers Research (blog)
AstraZeneca plc goes 'nuclear' on R&D spend to double sales
Shrinking pharmaceutical giant AstraZeneca's (LSE: AZN) chief executive Pascal Soriot is on record as saying he had no choice but to overhaul the company when he took over in October 2012 because "the company was imploding" due to the number of ...
Are Mediclinic International plc, AstraZeneca plc and Smith & Nephew plc the ...
Mediclinic International (LSE: MDC) was formed earlier this year when Abu Dhabi-based FTSE 250 firm Al Noor Hospitals combined with South African company Mediclinic.